FFPE Tissue Samples Market

ID: MRFR/HC/25530-HCR
128 Pages
Rahul Gotadki
Last Updated: May 25, 2026
FFPE Tissue Samples Market Research Report By Type (Prostate Tissue Samples, Colon Tissue Samples, Breast Tissue Samples, Lung Tissue Samples, Other Tissue Samples), By Application (Cancer Diagnostics, Drug Discovery, Biomarker Research, Personalized Medicine, Other Applications), By Format (Paraffin-Embedded (FFPE), Fresh Frozen Tissue (FFTF), Live Tissue, Other Formats), By Preservation Method (Formalin-Fixed, Paraffin-Embedded (FFPE), Cryopreserved, Snap-Frozen, Other Preservation Methods) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Healthcare, BY Type (USD Billion) | |
      1. 4.1.1 Prostate Tissue Samples | |
      2. 4.1.2 Colon Tissue Samples | |
      3. 4.1.3 Breast Tissue Samples | |
      4. 4.1.4 Lung Tissue Samples | |
      5. 4.1.5 Other Tissue Samples |
    2. 4.2 Healthcare, BY Application (USD Billion) | |
      1. 4.2.1 Cancer Diagnostics | |
      2. 4.2.2 Drug Discovery | |
      3. 4.2.3 Biomarker Research | |
      4. 4.2.4 Personalized Medicine | |
      5. 4.2.5 Other Applications |
    3. 4.3 Healthcare, BY Format (USD Billion) | |
      1. 4.3.1 Paraffin-Embedded (FFPE) | |
      2. 4.3.2 Fresh Frozen Tissue (FFTF) | |
      3. 4.3.3 Live Tissue | |
      4. 4.3.4 Other Formats |
    4. 4.4 Healthcare, BY Preservation Method (USD Billion) | |
      1. 4.4.1 Formalin-Fixed, Paraffin-Embedded (FFPE) | |
      2. 4.4.2 Cryopreserved | |
      3. 4.4.3 Snap-Frozen | |
      4. 4.4.4 Other Preservation Methods |
    5. 4.5 Healthcare, BY Region (USD Billion) | |
      1. 4.5.1 North America | | |
        1. 4.5.1.1 US | | |
        2. 4.5.1.2 Canada | |
      2. 4.5.2 Europe | | |
        1. 4.5.2.1 Germany | | |
        2. 4.5.2.2 UK | | |
        3. 4.5.2.3 France | | |
        4. 4.5.2.4 Russia | | |
        5. 4.5.2.5 Italy | | |
        6. 4.5.2.6 Spain | | |
        7. 4.5.2.7 Rest of Europe | |
      3. 4.5.3 APAC | | |
        1. 4.5.3.1 China | | |
        2. 4.5.3.2 India | | |
        3. 4.5.3.3 Japan | | |
        4. 4.5.3.4 South Korea | | |
        5. 4.5.3.5 Malaysia | | |
        6. 4.5.3.6 Thailand | | |
        7. 4.5.3.7 Indonesia | | |
        8. 4.5.3.8 Rest of APAC | |
      4. 4.5.4 South America | | |
        1. 4.5.4.1 Brazil | | |
        2. 4.5.4.2 Mexico | | |
        3. 4.5.4.3 Argentina | | |
        4. 4.5.4.4 Rest of South America | |
      5. 4.5.5 MEA | | |
        1. 4.5.5.1 GCC Countries | | |
        2. 4.5.5.2 South Africa | | |
        3. 4.5.5.3 Rest of MEA 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Healthcare | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Thermo Fisher Scientific (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Agilent Technologies (US) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Merck KGaA (DE) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 F. Hoffmann-La Roche Ltd (CH) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Illumina, Inc. (US) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 PerkinElmer, Inc. (US) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Bio-Techne Corporation (US) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Sakura Finetek Japan Co., Ltd. (JP) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies | |
      9. 5.2.9 Abcam plc (GB) | | |
        1. 5.2.9.1 Financial Overview | | |
        2. 5.2.9.2 Products Offered | | |
        3. 5.2.9.3 Key Developments | | |
        4. 5.2.9.4 SWOT Analysis | | |
        5. 5.2.9.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 NORTH AMERICA MARKET ANALYSIS |
    6. 6.3 US MARKET ANALYSIS BY TYPE |
    7. 6.4 US MARKET ANALYSIS BY APPLICATION |
    8. 6.5 US MARKET ANALYSIS BY FORMAT |
    9. 6.6 US MARKET ANALYSIS BY PRESERVATION METHOD |
    10. 6.7 CANADA MARKET ANALYSIS BY TYPE |
    11. 6.8 CANADA MARKET ANALYSIS BY APPLICATION |
    12. 6.9 CANADA MARKET ANALYSIS BY FORMAT |
    13. 6.10 CANADA MARKET ANALYSIS BY PRESERVATION METHOD |
    14. 6.11 EUROPE MARKET ANALYSIS |
    15. 6.12 GERMANY MARKET ANALYSIS BY TYPE |
    16. 6.13 GERMANY MARKET ANALYSIS BY APPLICATION |
    17. 6.14 GERMANY MARKET ANALYSIS BY FORMAT |
    18. 6.15 GERMANY MARKET ANALYSIS BY PRESERVATION METHOD |
    19. 6.16 UK MARKET ANALYSIS BY TYPE |
    20. 6.17 UK MARKET ANALYSIS BY APPLICATION |
    21. 6.18 UK MARKET ANALYSIS BY FORMAT |
    22. 6.19 UK MARKET ANALYSIS BY PRESERVATION METHOD |
    23. 6.20 FRANCE MARKET ANALYSIS BY TYPE |
    24. 6.21 FRANCE MARKET ANALYSIS BY APPLICATION |
    25. 6.22 FRANCE MARKET ANALYSIS BY FORMAT |
    26. 6.23 FRANCE MARKET ANALYSIS BY PRESERVATION METHOD |
    27. 6.24 RUSSIA MARKET ANALYSIS BY TYPE |
    28. 6.25 RUSSIA MARKET ANALYSIS BY APPLICATION |
    29. 6.26 RUSSIA MARKET ANALYSIS BY FORMAT |
    30. 6.27 RUSSIA MARKET ANALYSIS BY PRESERVATION METHOD |
    31. 6.28 ITALY MARKET ANALYSIS BY TYPE |
    32. 6.29 ITALY MARKET ANALYSIS BY APPLICATION |
    33. 6.30 ITALY MARKET ANALYSIS BY FORMAT |
    34. 6.31 ITALY MARKET ANALYSIS BY PRESERVATION METHOD |
    35. 6.32 SPAIN MARKET ANALYSIS BY TYPE |
    36. 6.33 SPAIN MARKET ANALYSIS BY APPLICATION |
    37. 6.34 SPAIN MARKET ANALYSIS BY FORMAT |
    38. 6.35 SPAIN MARKET ANALYSIS BY PRESERVATION METHOD |
    39. 6.36 REST OF EUROPE MARKET ANALYSIS BY TYPE |
    40. 6.37 REST OF EUROPE MARKET ANALYSIS BY APPLICATION |
    41. 6.38 REST OF EUROPE MARKET ANALYSIS BY FORMAT |
    42. 6.39 REST OF EUROPE MARKET ANALYSIS BY PRESERVATION METHOD |
    43. 6.40 APAC MARKET ANALYSIS |
    44. 6.41 CHINA MARKET ANALYSIS BY TYPE |
    45. 6.42 CHINA MARKET ANALYSIS BY APPLICATION |
    46. 6.43 CHINA MARKET ANALYSIS BY FORMAT |
    47. 6.44 CHINA MARKET ANALYSIS BY PRESERVATION METHOD |
    48. 6.45 INDIA MARKET ANALYSIS BY TYPE |
    49. 6.46 INDIA MARKET ANALYSIS BY APPLICATION |
    50. 6.47 INDIA MARKET ANALYSIS BY FORMAT |
    51. 6.48 INDIA MARKET ANALYSIS BY PRESERVATION METHOD |
    52. 6.49 JAPAN MARKET ANALYSIS BY TYPE |
    53. 6.50 JAPAN MARKET ANALYSIS BY APPLICATION |
    54. 6.51 JAPAN MARKET ANALYSIS BY FORMAT |
    55. 6.52 JAPAN MARKET ANALYSIS BY PRESERVATION METHOD |
    56. 6.53 SOUTH KOREA MARKET ANALYSIS BY TYPE |
    57. 6.54 SOUTH KOREA MARKET ANALYSIS BY APPLICATION |
    58. 6.55 SOUTH KOREA MARKET ANALYSIS BY FORMAT |
    59. 6.56 SOUTH KOREA MARKET ANALYSIS BY PRESERVATION METHOD |
    60. 6.57 MALAYSIA MARKET ANALYSIS BY TYPE |
    61. 6.58 MALAYSIA MARKET ANALYSIS BY APPLICATION |
    62. 6.59 MALAYSIA MARKET ANALYSIS BY FORMAT |
    63. 6.60 MALAYSIA MARKET ANALYSIS BY PRESERVATION METHOD |
    64. 6.61 THAILAND MARKET ANALYSIS BY TYPE |
    65. 6.62 THAILAND MARKET ANALYSIS BY APPLICATION |
    66. 6.63 THAILAND MARKET ANALYSIS BY FORMAT |
    67. 6.64 THAILAND MARKET ANALYSIS BY PRESERVATION METHOD |
    68. 6.65 INDONESIA MARKET ANALYSIS BY TYPE |
    69. 6.66 INDONESIA MARKET ANALYSIS BY APPLICATION |
    70. 6.67 INDONESIA MARKET ANALYSIS BY FORMAT |
    71. 6.68 INDONESIA MARKET ANALYSIS BY PRESERVATION METHOD |
    72. 6.69 REST OF APAC MARKET ANALYSIS BY TYPE |
    73. 6.70 REST OF APAC MARKET ANALYSIS BY APPLICATION |
    74. 6.71 REST OF APAC MARKET ANALYSIS BY FORMAT |
    75. 6.72 REST OF APAC MARKET ANALYSIS BY PRESERVATION METHOD |
    76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
    77. 6.74 BRAZIL MARKET ANALYSIS BY TYPE |
    78. 6.75 BRAZIL MARKET ANALYSIS BY APPLICATION |
    79. 6.76 BRAZIL MARKET ANALYSIS BY FORMAT |
    80. 6.77 BRAZIL MARKET ANALYSIS BY PRESERVATION METHOD |
    81. 6.78 MEXICO MARKET ANALYSIS BY TYPE |
    82. 6.79 MEXICO MARKET ANALYSIS BY APPLICATION |
    83. 6.80 MEXICO MARKET ANALYSIS BY FORMAT |
    84. 6.81 MEXICO MARKET ANALYSIS BY PRESERVATION METHOD |
    85. 6.82 ARGENTINA MARKET ANALYSIS BY TYPE |
    86. 6.83 ARGENTINA MARKET ANALYSIS BY APPLICATION |
    87. 6.84 ARGENTINA MARKET ANALYSIS BY FORMAT |
    88. 6.85 ARGENTINA MARKET ANALYSIS BY PRESERVATION METHOD |
    89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE |
    90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION |
    91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY FORMAT |
    92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRESERVATION METHOD |
    93. 6.90 MEA MARKET ANALYSIS |
    94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY TYPE |
    95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION |
    96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY FORMAT |
    97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY PRESERVATION METHOD |
    98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY TYPE |
    99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION |
    100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY FORMAT |
    101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY PRESERVATION METHOD |
    102. 6.99 REST OF MEA MARKET ANALYSIS BY TYPE |
    103. 6.100 REST OF MEA MARKET ANALYSIS BY APPLICATION |
    104. 6.101 REST OF MEA MARKET ANALYSIS BY FORMAT |
    105. 6.102 REST OF MEA MARKET ANALYSIS BY PRESERVATION METHOD |
    106. 6.103 KEY BUYING CRITERIA OF HEALTHCARE |
    107. 6.104 RESEARCH PROCESS OF MRFR |
    108. 6.105 DRO ANALYSIS OF HEALTHCARE |
    109. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
    110. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
    111. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE |
    112. 6.109 HEALTHCARE, BY TYPE, 2024 (% SHARE) |
    113. 6.110 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion) |
    114. 6.111 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
    115. 6.112 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion) |
    116. 6.113 HEALTHCARE, BY FORMAT, 2024 (% SHARE) |
    117. 6.114 HEALTHCARE, BY FORMAT, 2024 TO 2035 (USD Billion) |
    118. 6.115 HEALTHCARE, BY PRESERVATION METHOD, 2024 (% SHARE) |
    119. 6.116 HEALTHCARE, BY PRESERVATION METHOD, 2024 TO 2035 (USD Billion) |
    120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    121. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.2.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.2.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.2.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.3.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.3.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.3.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.3.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.4.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.4.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.4.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.4.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.5.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.5.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.5.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.5.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.6.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.6.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.6.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.6.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.7.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.7.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.7.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.7.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.8.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.8.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.8.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.8.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.9.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.9.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.9.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.9.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.10.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.10.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.10.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.10.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.11.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.11.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.11.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.11.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.12.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.12.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.12.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.12.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.13.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.13.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.13.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.13.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.14.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.14.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.14.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.14.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.15.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.15.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.15.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.15.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.16.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.16.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.16.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.16.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.17.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.17.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.17.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.17.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.18.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.18.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.18.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.18.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.19.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.19.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.19.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.19.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.20.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.20.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.20.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.20.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.21.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.21.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.21.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.21.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.22.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.22.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.22.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.22.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.23.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.23.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.23.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.23.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.24.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.24.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.24.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.24.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.25.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.25.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.25.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.25.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.26.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.26.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.26.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.26.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.27.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.27.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.27.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.27.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.28.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.28.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.28.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.28.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.29.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.29.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.29.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.29.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.30.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.30.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.30.3 BY FORMAT, 2025-2035 (USD Billion) | |
      4. 7.30.4 BY PRESERVATION METHOD, 2025-2035 (USD Billion) |
    151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.31.1 |
    152. 7.32 ACQUISITION/PARTNERSHIP | |

Healthcare Market Segmentation

Healthcare By Type (USD Billion, 2025-2035)

  • Prostate Tissue Samples
  • Colon Tissue Samples
  • Breast Tissue Samples
  • Lung Tissue Samples
  • Other Tissue Samples

Healthcare By Application (USD Billion, 2025-2035)

  • Cancer Diagnostics
  • Drug Discovery
  • Biomarker Research
  • Personalized Medicine
  • Other Applications

Healthcare By Format (USD Billion, 2025-2035)

  • Paraffin-Embedded (FFPE)
  • Fresh Frozen Tissue (FFTF)
  • Live Tissue
  • Other Formats

Healthcare By Preservation Method (USD Billion, 2025-2035)

  • Formalin-Fixed, Paraffin-Embedded (FFPE)
  • Cryopreserved
  • Snap-Frozen
  • Other Preservation Methods